Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair

Randomized Clinical Trial: Transverse Abdominis Plane Block Versus no Block in Laparoscopic Ventral Hernia Repair

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03342040

Enrollment

Registered

2017-11-14

Start date

2017-10-15

Completion date

2019-02-01

Last updated

2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventral Hernia

Keywords

TAP block, laparoscopic IPOM, post operative pain

Brief summary

The current study aims to determine if transverse abdominis plane block using local anesthetic agents (bupivacaine 0.25% + Ropivacaine 0.20%) decreases the post operative pain and helps in early mobilization or discharge from hospital in patients undergoing laparoscopic ventral hernia repair.

Detailed description

Patients meeting inclusion criteria would be randomised after admission. Those patients in experimental arm shall receive the TAP block under USG guidance while those in control arm do not receive any block. Surgery shall be proceeded in the usual manner in all the patients and assessment for pain starts in the immediate post operative or recovery room after the patient is completely conscious. The total amount of analgesic required by the patient is measured. Pain assessment is done using the visual analog scale (VAS) at regular intervals until follow up review.

Interventions

PROCEDURELaparoscopic ventral hernia repair with TAP block

Transverse abdominis plane block is given under ultrasound guidance during laparoscopic ventral hernia surgery

PROCEDURELaparoscopic ventral hernia repair without TAP block

No block administered during Laparoscopic ventral hernia surgery

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Masking description

Participant and assessors are masked

Intervention model description

Prospective double blinded balanced allocation, randomized clinical trial

Eligibility

Sex/Gender

ALL

Age

15 Years to 75 Years

Healthy volunteers

Inclusion criteria

* All patients undergoing laparoscopic ventral hernia repair during the study period

Exclusion criteria

* Age \<15 or greater than 75 years * ASA \> 3 * Obstructed , recurrent or strangulated hernia * Lap assisted open hernia repair * Patients undergoing component separation * Parastomal hernia, spigelian hernia, lumbar hernia * Patients with Chronic kidney disease, bronchial asthma * Patients allergic to bupivacaine or NSAIDs * Not willing to participate

Design outcomes

Primary

Measure	Time frame	Description
Post operative cumulative analgesic requirement	24 hours after surgery	The amount of analgesic required by the patient during hospital stay

Secondary

Measure	Time frame	Description
Post-operative hospital stay	7 days from primary surgery	The time taken to get discharged from the hospital

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026